Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 DNA microarray industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Type trends
2.1.5 Application trends
2.1.6 End-user trends
Chapter 3 DNA Microarray Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing adoption of DNA microarray for various applications
3.2.1.2 Increasing prevalence of genetic disorders and cancers
3.2.1.3 Growing research activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost involved in the sequencing
3.2.2.2 Availability of cost effective alternative
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By type
3.3.3 By application
3.3.4 By end-user
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 DNA Microarray Market, By Product, 2018 - 2032 (USD Million)
5.1 Key trends, by product
5.2 Consumables
5.3 Instruments
5.4 Software & services
Chapter 6 DNA Microarray Market, By Type, 2018 - 2032 (USD Million)
6.1 Key trends, by type
6.2 Complementary DNA microarrays
6.3 Oligonucleotide DNA microarrays
6.4 Other types
Chapter 7 DNA Microarray Market, By Application, 2018 - 2032 (USD Million)
7.1 Key trends, by application
7.2 Gene expression analysis
7.3 Genotyping
7.4 Transcription factor binding analysis
7.5 Other applications
Chapter 8 DNA Microarray Market, By End-user, 2018 - 2032 (USD Million)
8.1 Key trends, by end-user
8.2 Academic & research institute
8.3 Pharmaceutical and biotechnology companies
8.4 Diagnostic centers
8.5 Hospitals and clinics
8.6 Other end-users
Chapter 9 DNA Microarray Market, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific, Inc
10.2 QIAGEN
10.3 Illumina, Inc.
10.4 Agilent Technologies, Inc.
10.5 Merck & Co., Inc.
10.6 bioMérieux SA
10.7 PerkinElmer, Inc.
10.8 Bio-Rad Laboratories
10.9 Arrayit Corporation
10.10 Takara Bio Inc
